Cmed, a full service CRO specialized in the design and delivery of both innovative and traditional early phase I to IIb patient clinical trials, has been invited to share its early phase clinical research expertise at leading industry events in the coming months.
Geoff Fatzinger, Cmed’s Vice President of Global Medical and Regulatory Affairs, is presenting the session “Adaptive Trials: A Global Regulatory Perspective” at Smart Trials 2014 in London, UK, on Wednesday April 9 at 2.30pm GMT. Geoff’s presentation will take an overview of adaptive designs in early phase clinical trials and the benefits this approach can bring, with a particular focus on regulatory issues and key components which must be considered when implementing an adaptive design. Conference attendees are also encouraged to visit Cmed in the exhibit hall.
Joanne Hollenbach, Cmed’s Chief Operating Officer, US, will be presenting at the Outsourcing in Clinical Trials East Coast conference in Philadelphia, USA on May 13 at 4pm EST. The presentation entitled “How to Determine the Feasibility of a Proposed Alternative Clinical Monitoring Strategy” will provide a rationale for Risk Based Monitoring and explore when it is appropriate and when it is not, as well as explain the limits of Risk Based Monitoring, even in trials where it is appropriate to use. Attendees will be able to hear more from Joanne on booth #13.
Cmed will be announcing further expert presentations at industry leading events in the coming weeks.
Cmed´s approach has been to build an organization in response to the current challenges being faced by the biopharmaceutical industry, with specialist capabilities and expertise, readily available to support the industry through the design and operational delivery of traditional, innovative and/or complex early Phase I to IIb clinical trials, as well as Phase III studies. Cmed accomplishes this through deep regulatory and medical insight, superior drug development consulting, robust clinical operations, in-depth biometrics solutions, as well its in-house eClinical technology, Timaeus.
To pre-arrange a meeting with Cmed at Smart Trials 2014 or Outsourcing in Clinical Trials East Coast, email info@cmedresearch.com.
- ends-
About Cmed Group (www.CmedGroup.com)
Cmed Group is an innovative clinical trials services and advanced software provider which includes two divisions: Cmed Clinical Services and Cmed Technology.
Cmed Clinical Services (www.CmedResearch.com) is a CRO that provides full service trial delivery teams (project management, clinical monitoring, data management, biostatistics, medical affairs, regulatory, consulting, and medical writing services) as well as stand-alone solutions across all its services, including Biometrics functional services. It combines experience with using many commercially available technologies but also uses trusted and innovative software developed by Cmed Technology, including its award winning system, Timaeus.
Cmed Technology (www.CmedTechnology.com) offers Timaeus: a single platform for electronic trial design, paper and electronic data capture, monitoring, coding, data management and reporting. Timaeus, which uses advanced distributed cloud computing and mobile technologies, is designed to respond on-demand to the needs of investigators, data managers and study teams. Timaeus has been used in every phase of clinical research – including early phase, pivotal and late phase studies as well as in emerging markets.
